INHIBITOR OF RENAL FIBROSIS IN DIABETIC NEPHROPATHY

Provided is a composition that comprises citric acid, a pharmaceutically acceptable citric acid salt, a hydrate thereof or a mixture of the same. By administering or taking this composition, renal fibrosis in diabetic nephropathy is inhibited. L'invention concerne une composition qui comprend d...

Full description

Saved in:
Bibliographic Details
Main Authors YAMAUCHI, NOBORU, NAKAI, TOSHIKI, UEYAMA, SHIGEKI, FUKUI, MICHIAKI, HASHIMOTO, YOSHITAKA
Format Patent
LanguageEnglish
French
Published 23.04.2020
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Provided is a composition that comprises citric acid, a pharmaceutically acceptable citric acid salt, a hydrate thereof or a mixture of the same. By administering or taking this composition, renal fibrosis in diabetic nephropathy is inhibited. L'invention concerne une composition qui comprend de l'acide citrique, un sel d'acide citrique pharmaceutiquement acceptable, un hydrate de celui-ci ou un mélange de ceux-ci. L'administration ou la prise de cette composition permet d'inhiber une fibrose rénale dans une néphropathie diabétique.
Bibliography:Application Number: CA20193116695